ICB BIOTECHNOLOGY INVESTMENTS LTD Inactive Instrument
Icb Biotechnology Investments Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
IL0010970544
Investment Banking & Brokerage Services
| Sales 2022 | 644K 173K 64.4M 13.8M | Sales 2023 | 2.88M 774K 288M 61.79M | Capitalization | 7.07M 1.9M 707M 152M |
|---|---|---|---|---|---|
| Net income 2022 | -32M -8.59M -3.2B -686M | Net income 2023 | -6M -1.61M -600M -129M | EV / Sales 2022 | 21.1 x |
| Net Debt 2022 | 589K 158K 58.9M 12.62M | Net Debt 2023 | 4.04M 1.09M 404M 86.7M | EV / Sales 2023 | 3.85 x |
| P/E ratio 2022 |
-0.4
x | P/E ratio 2023 |
-1.14
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 58.64% |
More Fundamentals
* Assessed data
| Managers | Title | Age | Since |
|---|---|---|---|
Eliezer Mizroach
CEO | Chief Executive Officer | 51 | 23/01/22 |
Dorit Kreiner
DFI | Director of Finance/CFO | 52 | 31/03/22 |
Chen Munitz
CIO | Chief Investment Officer | 49 | 23/01/22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Zvi Ziv
CHM | Chairman | 74 | 23/01/22 |
Gal Cohen
BRD | Director/Board Member | 51 | 02/04/22 |
Eliezer Mizroach
CEO | Chief Executive Officer | 51 | 23/01/22 |
Silver Castle Holdings Ltd, former Israel China Biotechnology Icb Ltd, is an Israel-based company engaged in financial services industry. It operates as asset management and hedge fund investment house for digital currencies and advise initial coin offering (ICO) and invest in blockchain technology initiatives.
| 1st Jan change | Capi. | |
|---|---|---|
| -5.63% | 28.47B | |
| -6.85% | 15.66B | |
| +3.15% | 14.47B | |
| +47.18% | 12.86B | |
| -14.04% | 12.28B | |
| -3.22% | 9.02B | |
| -12.90% | 7.04B | |
| +8.25% | 5.99B | |
| -4.01% | 5.68B |
